Sunshine Biopharma (NASDAQ:SBFM) Announces Earnings Results

Sunshine Biopharma (NASDAQ:SBFM) issued its quarterly earnings results on Tuesday. The company reported ($0.94) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $9.00 by ($9.94), Zacks reports. The business had revenue of $8.44 million for the quarter. Sunshine Biopharma had a negative return on equity of 16.09% and a negative net margin of 12.07%.

Sunshine Biopharma Stock Performance

Shares of NASDAQ SBFM traded up $0.04 during mid-day trading on Thursday, hitting $2.72. The stock had a trading volume of 191,163 shares, compared to its average volume of 128,353. The company has a 50 day moving average of $2.96 and a two-hundred day moving average of $1.65. Sunshine Biopharma has a twelve month low of $2.42 and a twelve month high of $637.20. The firm has a market cap of $3.32 million, a PE ratio of -0.01 and a beta of 1.38.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.